Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Fort Lauderdale, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Sunshine Biopharma Inc. has filed 405 SEC EDGAR filings since 25 May 2007

SEC filing history

Showing 251-275 of 374 matching filings.

Per page
25
Current page
11
PRE 14C File 000-52898

INFORMATION STATEMENT

Filing date
28 Nov 2018
Reporting date
28 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-52898

QUARTERLY REPORT

Filing date
16 Nov 2018
Reporting date
30 Sep 2018
Next action
Verify source filing
NT 10-Q File 000-52898

PRIMARY DOCUMENT

Filing date
14 Nov 2018
Reporting date
30 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
RW File 333-227748

RW

Filing date
31 Oct 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEL AM File 333-227748

DEL AM

Filing date
17 Oct 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-227748

REGISTRATION STATEMENT

Filing date
09 Oct 2018
Reporting date
Not listed
Next action
Verify source filing
8-K File 000-52898

CURRENT REPORT

Filing date
14 Sep 2018
Reporting date
10 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Sep 2018
Reporting date
27 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Sep 2018
Reporting date
27 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Sep 2018
Reporting date
27 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-52898

QUARTERLY REPORT

Filing date
17 Aug 2018
Reporting date
30 Jun 2018
Next action
Verify source filing
NT 10-Q File 000-52898

LATE FILING NOTIFICATION

Filing date
14 Aug 2018
Reporting date
30 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
28 Jun 2018
Reporting date
20 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
28 Jun 2018
Reporting date
20 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
28 Jun 2018
Reporting date
20 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-52898

QUARTERLY REPORT

Filing date
22 May 2018
Reporting date
31 Mar 2018
Next action
Verify source filing
NT 10-Q File 000-52898

NT 10-Q

Filing date
15 May 2018
Reporting date
31 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-52898

ANNUAL REPORT

Filing date
02 Apr 2018
Reporting date
31 Dec 2017
Next action
Verify source filing
8-K File 000-52898

CURRENT REPORT

Filing date
04 Jan 2018
Reporting date
01 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-52898

QUARTERLY REPRORT

Filing date
15 Nov 2017
Reporting date
30 Sep 2017
Next action
Verify source filing
NT 10-Q File 000-52898

LATE FILING NOTIFICATION

Filing date
13 Nov 2017
Reporting date
30 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Sep 2017
Reporting date
20 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Sep 2017
Reporting date
20 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Sep 2017
Reporting date
20 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52898

CURRENT REPORT

Filing date
05 Sep 2017
Reporting date
29 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .